Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
8.6%
% of FHLC's 405 holdings also in GDOC
75.6%
% of GDOC's 48 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.2% | 8.4% | 8.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% | 2.8% | 2.2% |
|
DANAHER CORP | 3.2% | 2.1% | 2.1% |
|
INTUITIVE SURGICAL INC | 1.8% | 4.9% | 1.8% |
|
GILEAD SCIENCES INC | 1.7% | 2.9% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to GDOC
|
UNITEDHEALTH GROUP INC | 8.0% |
|
JOHNSON & JOHNSON | 6.9% |
|
MERCK & CO. INC. | 4.8% |
|
ABBVIE INC | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.5% |
|
PFIZER INC | 3.4% |
|
ABBOTT LABORATORIES | 3.1% |
|
AMGEN INC | 2.5% |
 |
MEDTRONIC PLC | 1.9% |
|
ANTHEM INC | 1.9% |
FHLC Underweight Relative to GDOC
 |
ASTRAZENECA PLC | -5.2% |
|
BOSTON SCIENTIFIC CORP | -4.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% |
|
INTUITIVE SURGICAL INC | -3.1% |
 |
CSL LIMITED | -2.9% |
|
BIOGEN IDEC INC | -2.7% |
|
SEATTLE GENETICS INC | -2.6% |
|
NEUROCRINE BIOSCIENCES INC | -2.6% |
|
BIOMARIN PHARMACEUTICAL INC | -2.6% |
|
ZIMMER HOLDINGS INC | -2.3% |